Silicon Republic February 6, 2024
The Irish medical device company will use the fresh funds for its first human clinical trial.
Galway-based Ceroflo, which is developing a stroke treatment in the form of a stent, has raised €6.4m in funding.
The funding round was led by Galway-based accounting firm, DHKN, which raised €5m in an employment investment incentive scheme (EIIS), while the remaining €1.4m came from a variety of medtech entrepreneurs and key opinion leaders in the area of stroke.
Ceroflo was co-founded by Eamon Brady and John O’Dea, along with a team of stroke interventionists Prof Tommy Andersson of Karolinska University Hospital in Sweden, Dr Leonard Yeo of National University of Health Singapore and Dr Paul Bhogal of Royal London Hospital.
The company’s stent...
Today's Sponsors
Today's Sponsor